The distribution of TILs changed following pIL-12 GET treatment resulting in an expansion of CD3+ T cells infiltrating in the tumor environment, which involved CD4+ and CD8+ T cells (Figure 3A) compared with no TX, EP1, EP2 and pIL-12 injection only groups. The gene discussed is CD8A; the disease is neoplasm.